Trial Profile
An Open-label, Multi-center Study to Evaluate the Effects of ASA404 Alone and in Combination With Taxane-based Chemotherapy on the Pharmacokinetics of Simvastatin, Caffeine, Omeprazole, and Diclofenac in Patients With Advanced Solid Tumour Malignancies.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2015
Price :
$35
*
At a glance
- Drugs Vadimezan (Primary) ; Caffeine; Diclofenac; Omeprazole; Simvastatin
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals
- 14 Feb 2011 New trial record